Muparfostat
- Generic Name
- Muparfostat
- Drug Type
- Small Molecule
- Chemical Formula
- C18H33O49PS10
- CAS Number
- 1020105-89-8
- Unique Ingredient Identifier
- P2BKS6T40H
Overview
Muparfostat (PI-88) is a mixture of highly sulfated, monophosphorylated mannose oligosaccharides, derived from the extracellular phosphomannan of the yeast Pichia (Hansenula) holstii, with potential antiangiogenic activity.
Background
Muparfostat (PI-88) is a mixture of highly sulfated, monophosphorylated mannose oligosaccharides, derived from the extracellular phosphomannan of the yeast Pichia (Hansenula) holstii, with potential antiangiogenic activity.
Indication
Investigated for use/treatment in hepatocellular carcinoma, liver cancer, melanoma, and multiple myeloma.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath